Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
. .
This randomized trial compared rituximab with cyclophosphamide followed by azathioprine in severe ANCA-associated vasculitis. This noninferiority trial showed that there was no difference at 18 months for the induction and maintenance of remissions between groups.
Recent Comments